Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Imugene Ltd (OP: IUGNF )

0.0550 -0.0008 (-1.43%)
Streaming Delayed Price Updated: 2:52 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 54,987
Open 0.0568
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0558
Today's Range 0.0550 - 0.0570
52wk Range 0.0200 - 0.1050
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia and the UK for a new PD1-Vaxx Phase 2 colorectal (CRC) cancer clinical... 
Via TheNewswire.com
Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial
--News Direct-- 
Via News Direct

Performance

YTD
-38.89%
-38.89%
1 Month
-28.57%
-28.57%
3 Month
-31.25%
-31.25%
6 Month
+83.33%
+83.33%
1 Year
-41.11%
-41.11%

More News

Read More
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Via TheNewswire.com
Exposures Product Safety
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Via News Direct
Exposures Product Safety
Imugene thrilled as first patient dosed in Phase 1 OASIS trial
Via TheNewswire.com
Imugene thrilled as first patient dosed in Phase 1 OASIS trial
Via News Direct
Imugene talks VAXINIA MAST trial and corporate ambition
Via News Direct
Imugene talks VAXINIA MAST trial and corporate ambition
Via TheNewswire.com
Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
Via TheNewswire.com
Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
Via News Direct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.